Short answer
BIOLIFE SOLUTIONS INC (BLFS) filed an 8-K current report with the SEC on June 3, 2026 reporting Item 7.01 (Regulation FD Disclosure). Investor presentation issued June 3, 2026 for Jefferies Global Healthcare Conference and broader investor meetings.
BIOLIFE SOLUTIONS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Investor presentation issued June 3, 2026 for Jefferies Global Healthcare Conference and broader investor meetings
- Exhibit 99.1 contains management’s presentation materials, potentially updating investors on strategy and outlook
- Presentation available through BioLife Solutions’ investor-relations website
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other BIOLIFE SOLUTIONS INC 8-K filings
Get the next BLFS 8-K as it lands
Follow BLFS for push alerts, or ask the research agent what this filing means.